查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1666158

全球微波消融设备市场 - 2025 年至 2033 年

Global Microwave Ablation Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 210 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球微波消融设备市场规模达到 3.7816 亿美元，预计到 2033 年将达到 11.4574 亿美元，2025-2033 年预测期内的复合年增长率为 13.0%。

微波消融设备是利用微波能量破坏异常组织（如肿瘤或有害生长物）的医疗仪器。它们发射高频电磁波，引起组织中的水分子振动并产生热量，导致凝固性坏死。它们广泛用于肿瘤学治疗肝臟、肺臟、肾臟、骨肿瘤、心血管、泌尿和妇科疾病。与其他热消融技术相比，微波消融具有更深的组织穿透力、更高的温度和更快的治疗时间。

市场动态：

驱动因素与约束因素

癌症和其他慢性疾病发生率不断上升

微波消融设备市场的发展受到癌症和其他需要微创治疗的慢性疾病发生率上升的推动。由于全球肝臟、肺臟和肾臟肿瘤的负担，与传统手术方法相比，微波消融具有手术时间更快、组织破坏效率更高、併发症更少等特征。医院和门诊手术中心采用影像导引消融技术也推动了市场成长。

例如，根据美国癌症协会根据中央癌症登记处和国家卫生统计中心的资料预测，到 2024 年，美国将出现 2,001,140 例新癌症病例和 611,720 例死亡病例。

严格的监管审批

由于 FDA 和 EMA 严格的监管审批和合规要求，微波消融设备市场面临重大挑战。这些指南确保设备在进入市场之前的安全性和有效性。审批过程非常耗时，需要大量的临床试验、文件和品质控制措施。这可能会延迟产品发布、增加成本和复杂性，这可能会限制市场成长。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 癌症和其他慢性疾病发生率不断上升
    • 限制
      • 严格的监管审批
    • 机会
    • 影响分析

第五章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章：按组件类型

  • 发电机
  • 配电系统
  • 配件

第 7 章：按应用

  • 肿瘤学
  • 心血管
  • 泌尿科
  • 骨科
  • 其他的

第 8 章：按最终用户

  • 医院
  • 门诊手术中心
  • 诊所

第九章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • AngioDynamics
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Medtronic Plc
  • Boston Scientific Corporation
  • Johnson & Johnson Inc
  • Emblation
  • MedWaves, Inc
  • Symple Surgical
  • Urologix, LLC
  • Varian Medical Systems Inc
  • Huber Suhner
  • Similar data will be provided for each market player.
  • 米拉玛实验室有限公司
    • 管道产品描述
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估计和预测
  • 简单外科手术
  • 将为每个市场参与者提供类似的资料。

第 12 章：附录

简介目录
Product Code: MD9150

The Global Microwave Ablation Devices Market reached US$ 378.16 million in 2024 and is expected to reach US$ 1145.74 million by 2033, growing at a CAGR of 13.0% during the forecast period 2025-2033.

Microwave ablation devices are medical instruments that use microwave energy to destroy abnormal tissues, such as tumors or unwanted growths. They emit high-frequency electromagnetic waves, causing water molecules in tissues to vibrate and produce heat, leading to coagulative necrosis. They are widely used in oncology for treating liver, lung, kidney, bone tumors, cardiovascular, urological, and gynecological procedures. Compared to other thermal ablation techniques, microwave ablation offers deeper tissue penetration, higher temperatures, and faster treatment times.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Cancer and Other Chronic Diseases

The microwave ablation devices market is driven by the rising prevalence of cancer and other chronic diseases requiring minimally invasive treatments. With the global burden of liver, lung, and kidney tumors, microwave ablation offers faster procedure times, higher tissue destruction efficiency, and reduced complications compared to traditional surgical methods. The adoption of image-guided ablation techniques in hospitals and ambulatory surgical centers is also driving market growth.

For instance, according to American Cancer Society predicts in 2024, the US experienced 2,001,140 new cancer cases and 611,720 deaths, based on data from central cancer registries and the National Center for Health Statistics.

Stringent Regulatory Approvals

The microwave ablation devices market faces significant challenges due to stringent regulatory approvals and compliance requirements from the FDA and EMA. These guidelines ensure safety and efficacy of devices before they reach the market. The approval process is time-consuming and requires extensive clinical trials, documentation, and quality control measures. This can delay product launches, increase costs, and complexity, potentially limiting market growth.

Segment Analysis

The global Microwave Ablation Devices market is segmented based on Component Type, Application, End User and Region.

Component Type:

Generator segment is expected to dominate the Microwave Ablation Devices market share

The generator segment holds a major portion of the microwave ablation devices market share and is expected to continue to hold a significant portion of the microwave ablation devices market share during the forecast period.

Microwave ablation devices rely on generators for energy generation, controlling the frequency, power output, and duration of microwave emissions. Advancements in generator technology, including improved energy efficiency, real-time monitoring, and integration with imaging systems, enhance the accuracy and safety of ablation procedures. The growing demand for generators with higher power output and better thermal control drives market innovations, contributing to the expansion of microwave ablation therapies.

End User:-

Hospitals segment is the fastest-growing segment in Microwave Ablation Devices market share

The hospitals segment is the fastest-growing segment in the Microwave Ablation Devices market share and is expected to hold the market share over the forecast period.

Hospitals are leading the market in microwave ablation devices due to their primary role in healthcare. With increasing cases of cancer and chronic diseases requiring ablation therapy, hospitals invest in advanced systems for minimally invasive treatment. Specialized oncology and radiology departments enable the integration of microwave ablation with imaging technologies like CT and ultrasound. Government funding, reimbursement policies, and skilled healthcare professionals support the widespread use of microwave ablation devices in clinical practice.

For instance, in January 2025, Sringeri Sharada Equitas (SSE) hospital in Chennai has introduced Microwave Ablation treatment for affordable cancer treatment and curing, using microwave energy to kill and shrink tumor cells in organs like kidney, lungs, and liver.

Geographical Analysis

North America is expected to hold a significant position in the Microwave Ablation Devices market share

North America holds a substantial position in the Microwave Ablation Devices market and is expected to hold most of the market share due to advanced healthcare infrastructure, minimally invasive procedures, and investment in medical technology innovation. Key players like Medtronic and Boston Scientific develop cutting-edge ablation technologies. The rising prevalence of cancer, particularly liver and lung cancer, and government initiatives for treatment also increase demand for microwave ablation procedures. Favorable reimbursement policies and skilled healthcare professionals further contribute to market expansion.

For instance, in July 2024, Siemens Healthineers' Varian has received FDA clearance for its IntelliBlate microwave ablation system, designed for soft tissue ablation. The system offers clinicians greater predictability, precision, and control, forming the foundation of a future-focused, integrated microwave ablation ecosystem.

Europe is growing at the fastest pace in the Microwave Ablation Devices market

Europe holds the fastest pace in the Microwave Ablation Devices market and is expected to hold most of the market share is driven by rising healthcare expenditure, increased awareness of minimally invasive cancer treatments, and advancements in imaging technology. Countries like Germany, France, and the UK are leading due to strong research and development, rising cancer cases, well-regulated healthcare policies, and funding for cancer treatment programs. The expansion of ambulatory surgical centers and preference for outpatient procedures also contribute to market growth.

For instance, in March 2024, Creo Medical Group has made significant progress in the field of minimally invasive surgical endoscopy for pre-cancer and cancer patients. Professor Pallav Shah and Dr Christopher Orton at the Royal Brompton Hospital have become the first specialists to perform a robotic guided microwave ablation of lung tissue in the same sitting as a diagnostic procedure. The procedure, which took three minutes, involved the ablation of a 27mm cancerous nodule in a patient's lung.

Competitive Landscape

The major global players in the Microwave Ablation Devices market include AngioDynamics, Medtronic Plc, Boston Scientific Corporation, Johnson & Johnson Inc, Emblation, MedWaves, Inc, Symple Surgical, Urologix, LLC, Varian Medical Systems Inc, Huber Suhner and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Microwave Ablation Devices market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 210 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Component Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Cancer and Other Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Approvals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Component Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 6.1.2. Market Attractiveness Index, By Component Type
  • 6.2. Generator*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Power Distribution System
  • 6.4. Accessories

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Oncology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiovascular
  • 7.4. Urology
  • 7.5. Orthopedic
  • 7.6. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Clinics

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. AngioDynamics*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Medtronic Plc
  • 11.3. Boston Scientific Corporation
  • 11.4. Johnson & Johnson Inc
  • 11.5. Emblation
  • 11.6. MedWaves, Inc
  • 11.7. Symple Surgical
  • 11.8. Urologix, LLC
  • 11.9. Varian Medical Systems Inc
  • 11.10. Huber Suhner
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. Miramar Labs, Inc*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Symple Surgical
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us